Related Experiment Video
Updated: Jul 21, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
Benjamin Panzer1, Christoph W Kopp2, Christoph Neumayer3
1Department of Cardiology, Wilhelminenspital, 1090 Vienna, Austria.
Toll-like receptors (TLRs) trigger inflammation and vascular issues during viral infections. This review details how TLRs promote blood clotting, impacting patient outcomes, particularly in cardiovascular disease.
Area of Science:
- Immunology
- Pathophysiology
- Vascular Biology
Background:
- Toll-like receptors (TLRs) are key mediators in viral infection pathogenesis.
- TLR activation induces pro-inflammatory responses that disrupt vascular homeostasis.
- Vascular injury promotes pro-thrombotic and pro-coagulatory states, leading to tissue damage.
Purpose of the Study:
- To review TLR signaling pathways involved in pro-thrombotic responses during viral infections.
- To highlight the role of TLRs in viral sensing and platelet activation.
- To discuss the impact of TLR-mediated thrombosis on patient outcomes, especially in cardiovascular disease.
Main Methods:
- Review of scientific literature on TLRs, viral infections, and thrombosis.
- Analysis of TLR signaling pathways and their pro-thrombotic effects.
- Focus on human TLRs and their clinical relevance.
Main Results:
- TLRs contribute to vascular dysfunction and thrombosis via inflammatory pathways.
- TLR-induced von Willebrand factor release and extracellular trap formation enhance thrombotic processes.
- TLR signaling directly impacts platelet activation during viral infections.
Conclusions:
- TLR-mediated pro-thrombotic responses are critical in viral infections.
- Understanding TLR pathways is crucial for managing thrombotic complications in viral infections, especially in patients with cardiovascular disease.
- Targeting TLR signaling may offer therapeutic strategies to improve outcomes.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

